Articles

Levi’s CEO says goal of $9 billion to $10 billion in annual revenue by 2027 will be pushed back

Levi Strauss & Co.’s goal of generating $9 billion to $10 billion in annual revenue by 2027 will be pushed back as the denim-clothing company is still seeing pressure on its customer after a long inflationary period, new Chief Executive Michelle Gass told the Financial Times.

This Social Security-style pension plan did everything right but still missed its benchmark

Even this top-performing pension plan has found it hard to beat low-fee passive investments.

Walmart’s stock rises toward a record as another analyst turns bullish

Walmart’s stock was headed back into record territory on Tuesday, as Truist turned bullish on the discount retailer amid accelerating market-share gains.

KKR’s Pete Stavros launches group promoting stock ownership for employees

Pete Stavros, a high-ranking executive at private-equity firm KKR & Co. Inc. known for rewarding staff with stock, on Tuesday launched an organization aimed at promoting employee stock ownership programs, or ESOPs.

Oil prices rise more than 2% after China announces stimulus measures

Oil futures rose Tuesday morning, lifted after China announced a range of stimulus measures aimed at boosting the economy of the world’s largest crude importer.

AutoZone’s stock drops after a rare profit miss, as U.S. sales come up short

AutoZone’s stock dropped in early Tuesday trading, after the auto-parts retailer reported quarterly earnings and sales that rose, but not enough to meet expectations, as U.S. results continued to underperform.

Snowflake stock drops on $2 billion debt plan

Snowflake outlined plans to raise $2 billion in debt to finance a $575 million share buyback plan and a series of possible acquisitions and strategic investments

Warren Buffett is a fan of energy stocks. Here’s one more strong buy signal.

Energy company insiders are purchasing far more shares than they’re selling. Here’s what they’re buying.

Biogen and Belgian partner UCB announce positive data from late-stage trial of lupus treatment

Biogen Inc.’s stock rose 2% early Tuesday, after the company and Belgian partner UCB announced positive results in a late-stage trial

Would a 60% tariff on Chinese imports hurt China or the U.S. more?

Trump’s proposal would be costly for Americans, but the Biden administration needs to do more.

Eli Lilly’s Alzheimer’s treatment Kisunla wins approval in Japan

Japan, with its rapidly aging population, is expected to have more than 5 million patients with dementia by 2030. Alzheimer’s is the most common form of dementia, accounting for more than 67% of cases, according to Lilly.

Treasury yields rise as China stimulus lifts global growth hopes

U.S. bond yields rose early Tuesday after the People’s Bank of China revealed an extensive stimulus package designed to revive the world’s second biggest economy.
1 809 810 811 812 813 2,370